Naveen Arunachalam Sakthiyendran

Mr. Naveen Arunachalam Sakthiyendran

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in Resuscitation
Verified
Journal Article
Closed access
CHCameron J. Hill
Cameron J. Hill
CSChelsea A. Sykora
Chelsea A. Sykora
SSStephen Schmugge
Stephen Schmugge
STSamuel Tate
Samuel Tate
MCMichael F.M. Cronin
Michael F.M. Cronin
COCharlene J. Ong
Charlene J. Ong

29 April 2025 in Critical Care Explorations
Verified
Journal Article
Open access
DVDivya Veerapaneni
Divya Veerapaneni
NSNaveen Arunachalam Sakthiyendran
Naveen Arunachalam Sakthiyendran
YDYili Du
Yili Du
LMLeigh Ann Bs Mallinger
Leigh Ann Bs Mallinger
ARAllyson Bs Reinert
Allyson Bs Reinert
COCharlene J. Md Ong
Charlene J. Md Ong
IMPORTANCE: In patients with traumatic brain injury (TBI), baseline pupillary assessment is routine; however, the occurrence rate and clinical significance of pupil abnormalities over the early course of hospitalization remain poorly characterized. OBJECTIVES: To determine whether the occurrence and frequency of pupil abnormalities within the first 72 hours of ICU admission are associated with unfavorable discharge outcomes and to assess whether incorporating this frequency improves the performance of an established prognostic model. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective observational study of adults admitted with a primary diagnosis of TBI to a single tertiary care ICU between 2018 and 2022. Inclusion criteria included at least three quantitative pupillometry assessments within the first 72 hours. MAIN OUTCOMES AND MEASURES: Quantitative pupillometry was used to calculate the Neurological Pupil index (NPi) at each assessment. Abnormalities were defined as NPi less than 3 in either eye, NPi asymmetry greater than or equal to 0.7, or pupil size asymmetry greater than or equal to 1 mm. The primary outcome was unfavorable discharge disposition (death, hospice, or long-term care). Multivariable logistic regression was used to evaluate the association between pupil abnormality frequency and outcomes, and model performance was compared using goodness-of-fit tests with and without pupil frequency added to the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model. RESULTS: Among 131 patients (median age, 59 yr; 30% women), 35% had an unfavorable discharge disposition. Pupil abnormalities occurred in 60% of mild, 61% of moderate, and 88% of severe TBI patients. For each 1% increase in the frequency of pupil abnormalities over 72 hours, the odds of unfavorable discharge increased by 3% (odds ratio, 1.03; 95% CI, 1.01–1.05). Adding pupil abnormality frequency to the IMPACT model improved its goodness-of-fit (χ2 = 5.24; p = 0.02). CONCLUSIONS AND RELEVANCE: Pupil abnormalities are common across TBI severities, particularly in severe cases. A higher frequency of abnormal pupil measurements within the first 72 hours is associated with unfavorable outcomes and significantly enhances the predictive performance of established TBI prognostic models. Serial quantitative pupillometry may offer clinically valuable, dynamic prognostic information in the acute care setting.

26 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DVDivya Veerapaneni
Divya Veerapaneni
NSNaveen Arunachalam Sakthiyendran
Naveen Arunachalam Sakthiyendran
SKSo Yeon Kim
So Yeon Kim
CNChuong Nguyen
Chuong Nguyen
ADAli Daneshmand
Ali Daneshmand
COCharlene J. Ong
Charlene J. Ong
Importance: In patients with traumatic brain injury (TBI), baseline pupillary assessment is common. However, the incidence and frequency of pupil abnormalities within the first several days remain poorly characterized. Objectives: Our aim was to test the association between pupil abnormality frequency over the first 72 hours of admission and clinical outcomes. Design: We conducted a retrospective observational study of patients with a primary diagnosis of TBI with at least three quantitative pupillometry measurements within 72 hours at a single-center ICU from 2018 to 2022. Outcomes and Measures: Neurological Pupil index (NPi), a quantitative composite metric for pupil reactivity, was obtained at each clinical neurologic assessment over 72 hours. Pupil measurements were defined as abnormal if they had a NPi of <3 in either eye, NPi asymmetry ≥0.7, or pupil size asymmetry ≥1mm. We tested the association of increased frequency of pupil abnormalities over 72 hours and unfavorable discharge disposition (death, hospice, or long-term care) using multivariable logistic regression, adjusting for confounders. We then compared whether the IMPACT model was improved by the frequency of pupil abnormalities using goodness-of-fit. Results: Of 131 patients, median age was 59 years, and 30% were women. Thirty-five percent had unfavorable discharge disposition. Pupil abnormalities occurred in 62%, 61%, and 88% of mild, moderate, and severe TBI patients, respectively. Odds ratio of unfavorable discharge for every 1% increase in pupil abnormality frequency was 1.03 (95% Cl, 1.01-1.05), equivalent to one additional abnormal pupil measurement within a 72-hour period. The adjusted IMPACT TBI model’s goodness-of-fit improved with pupil abnormality frequency ( X 2 =5.67, p =0.02). Conclusions and Relevance: Pupil abnormalities occur commonly in TBI and have the highest frequency in severe TBI. Increased pupil abnormality frequency is associated with unfavorable discharge disposition and improves performance of prognostic TBI models. Key Points: The goal of this study was to test the association between pupil abnormality frequency over the first 72 hours of admission and unfavorable discharge disposition and whether it improved the IMPACT model. In this retrospective observational study of 131 TBI patients at a single-center, we found that an increased frequency of pupil abnormalities across 72-hours significantly correlated with unfavorable discharge in patients and improved the IMPACT model’s goodness-of-fit. These findings highlight the potential of long-term pupillary metrics and their role as not only a prognostic indicator in patients but also a tool that improves the performance of prognostic TBI models.

14 February 2025 in Cureus
Verified
Journal Article
Open access
PDF file
NSNaveen Arunachalam Sakthiyendran
Naveen Arunachalam Sakthiyendran
VPVenkata Jaswanth Padala
Venkata Jaswanth Padala
MSMelinda Seide
Melinda Seide
JSJia Whei See
Jia Whei See
NSNagma Sabu
Nagma Sabu
UFUrooj Fatima
Urooj Fatima
Despite advancements in psychiatric treatments, many patients with treatment-resistant disorders are turning to neurosurgical interventions. These include neuromodulation-based surgeries such as deep brain stimulation (DBS) and ablative surgeries such as cingulotomy, offering relief for severe conditions such as post-traumatic stress disorder (PTSD), depression, schizophrenia, obsessive-compulsive disorder (OCD), anxiety, and substance use disorder. While "psychosurgery" has sparked debate due to concerns about patient well-being, recent studies indicate promising symptom improvement rates across various psychiatric conditions while also demonstrating overall safety. Neuromodulation techniques, such as DBS, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), have evolved in regard to their sensitivity and their ability to target specific brain regions to alleviate psychiatric symptoms. Despite their benefits, these therapies have been shown to elicit side effects such as memory loss and seizures in patients, which has sparked controversy in the use of this technology across clinicians and patients. Ablative therapies, on the other hand, are concerning for being overly invasive in their approach toward psychiatric care. Despite the stigma associated with these neurosurgical interventions for psychiatric care, these procedures often remain a last resort for many patients, highlighting the need for continued research to improve these treatments and expand options for those in need. In this narrative review, we examine the current literature to elicit an understanding of neurosurgical history in regard to psychiatric disorder treatment and its implications for clinical practice.

12 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSNaveen Arunachalam Sakthiyendran
Naveen Arunachalam Sakthiyendran
CCCaroline Cushman
Caroline Cushman
EHEvan James Hernandez
Evan James Hernandez
BMBrendan James MacKay
Brendan James MacKay
Background/Objectives: Cervical spinal cord injury (SCI) frequently causes tetraplegia and severe upper-limb dysfunction with substantial societal cost. Restoring finger extension is a priority, since even modest gains improve independence. Tendon transfer and supinator-to-posterior interosseous nerve transfer (SUP–PIN) both restore hand function, but their relative economic value is unclear. We assessed the lifetime cost-effectiveness of SUP–PIN versus tendon transfer and conservative management for finger extension in patients with mid-cervical SCIs who are candidates for both reconstructive strategies. Methods: A decision-analytic model combining a decision-tree front end with a lifetime Markov state-transition structure (one-year cycles, 3% annual discounting, half-cycle correction) compared SUP–PIN, tendon transfer, and conservative (nonoperative) care over a lifetime horizon, incorporating direct medical costs and indirect productivity losses. The outcomes were quality-adjusted life years (QALYs) accumulated over the horizon, using a willingness-to-pay threshold of $100,000/QALY. Success, complication, recovery, and return-to-work probabilities were drawn from the published literature. Deterministic, probabilistic, and two-way sensitivity analyses assessed robustness. Results: From the healthcare-sector perspective, conservative management was the least costly ($630.48; 14.84 QALYs) but least effective; nerve transfer was the most effective (18.55 QALYs) at $6485.84 and dominated tendon transfer, with an ICER versus conservative management of $1579/QALY, well below the $100,000/QALY threshold. From the societal perspective, nerve transfer was dominant, with the lowest lifetime cost ($903,937) and the highest effectiveness. Across the sensitivity analyses, nerve transfer was preferred under nearly all assumptions; tendon transfer was preferred only with ≥90% tendon success combined with ≤40% nerve-transfer success. Conclusions: In this decision-analytic model, SUP–PIN nerve transfer was projected to be economically favorable, yielding greater modeled effectiveness and lower lifetime costs than tendon transfer and conservative care under the stated assumptions. These modeled findings support further evaluation of nerve transfer in post-SCI rehabilitation algorithms and timely surgical referrals but do not, by themselves, establish clinical superiority, which requires a prospective comparative study.

23 October 2026 in Cells
Verified
Journal Article
Open access
PDF file
NSNaveen Arunachalam Sakthiyendran
Naveen Arunachalam Sakthiyendran
CCCaroline Cushman
Caroline Cushman
EHEvan James Hernandez
Evan James Hernandez
AIAnceslo Idicula
Anceslo Idicula
IVIan L. Valerio
Ian L. Valerio
BMBrendan James MacKay
Brendan James MacKay
Peripheral nerve injuries that lack a distal target are prone to symptomatic neuroma formation, yet durable, low-complexity solutions remain limited. We report the first clinical evaluation of a porcine submucosa large-diameter nerve cap (PSLDNC) with paired human histology, contextualized by a previously published preclinical rat study. A 49-year-old man with a mangled hand underwent partial hand amputation with median nerve stump capping using a 7-mm PSLDNC. Eight months later, during revisional trans-radial amputation, the original cap was explanted for histopathology and the median, ulnar, and superficial radial nerves were recapped. Clinically, both residual limb pain and phantom limb pain fell from 39/100 pre-revision to 0 by six and three months, respectively, and remained absent through 15 months; the patient discontinued gabapentin and demonstrated excellent prosthetic function (BAM-ULA 10/10). Histology of the explant showed organized micro-fascicular architecture with minimal collagen deposition and only mild axonal swirling; NF immunostaining demonstrated directional alignment and higher neurofilament density within the capped segment (2326 vs. 945 µm2 per 10,000 µm2 in a patient control). In that referenced study, capped nerves exhibited fully organized architecture by 12 weeks (axonal swirling score = 0), significantly greater NF-positive area than uncapped controls, minimal local tissue reactivity, and lower pain-related behavioral scores. Together, the human clinical course, human explant histology, and animal histology are consistent with a mechanism in which PSLDNCs confine and guide regenerating axons, allow space for exhaustion of axonal outgrowth, and limit aberrant outgrowth and fibrosis, alongside meaningful relief of neuroma-related pain. Because this is a single patient whose revision also included neuroma resection, nerve re-capping, and intramuscular burial of the stumps, the contribution of the cap cannot be isolated; the absence of an uncapped histologic control and of a clinical comparator further tempers inference. Nonetheless, these data support nerve capping as a feasible, technically straightforward adjunct for neuroma prevention and symptom control, meriting prospective, controlled evaluation and longer-term follow-up.